Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I

David R. Clemmons (Inventor), Laura A. Maile (Inventor)

Research output: ResearchPatent

Abstract

The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.
LanguageEnglish
Patent number8206706
IPCA61K 39/395 (20060101)
StatePublished - 1800

Fingerprint

Insulin-Like Growth Factor I
Integrins
Cysteine
Peptides

Cite this

Clemmons, D. R., & Maile, L. A. (1800). IPC No. A61K 39/395 (20060101). Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I (Patent No. 8206706.)

Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I. / Clemmons, David R. (Inventor); Maile, Laura A. (Inventor).

IPC No.: A61K 39/395 (20060101). Patent No.: 8206706.

Research output: ResearchPatent

Clemmons, DR & Maile, LA 1800, Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I, Patent No. 8206706, IPC No. A61K 39/395 (20060101).
Clemmons DR, Maile LA, inventors. Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I. A61K 39/395 (20060101). 1800
Clemmons, David R. (Inventor) ; Maile, Laura A. (Inventor). / Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I. IPC No.: A61K 39/395 (20060101). Patent No.: 8206706.
@misc{e5e96eee2afb48b58a53739ab70cdc40,
title = "Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I",
abstract = "The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.",
author = "Clemmons, {David R.} and Maile, {Laura A.}",
note = "Status: published applicationnumber: 12/388,045 usclass: 424/130.1 ; 424/141.1 applicationnumber: 12/388,045; 8206706; A61K 39/395 (20060101)",
year = "1800",
type = "Patent",

}

TY - PAT

T1 - Method for Enhancing or Inhibiting Insulin-Like Growth Factor -I

AU - Clemmons,David R.

AU - Maile,Laura A.

N1 - Status: published applicationnumber: 12/388,045 usclass: 424/130.1 ; 424/141.1 applicationnumber: 12/388,045

PY - 1800

Y1 - 1800

N2 - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

AB - The present invention provides .alpha.V.beta.3 integrin cysteine loop domain agonists and antagonists (including peptide agonists and antagonists and analogs thereof), along with methods of using the same.

M3 - Patent

M1 - 8206706

ER -